公司简介

ABOUT US

Shenzhen Efung Capital is one of the earliest venture capital institutions that specialized in biomedicine investment in China. Efung has a high-caliber management team and an experienced investment team, which consist of MDs/PhDs graduated from professional institutions at home and abroad. It focuses on medical and healthcare sectors, especially in VC and PE investment in biopharmaceuticals and high-end medical devices. Throughout these years, Efung has explored profoundly the potentials of healthcare industry, and has invested over 50 prominent companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, Apexigen and Centrexion et al.

 

Efung Capital has demonstrated a solid track record, and has achieved strong revenue and earnings growth. It was recognized as “Zero2IPO Group2020 Best Healthcare Investment Institution TOP30”, “ChinaVenture 2019 Best Exit Cases TOP10”and “The Most Dynamic Pharmaceutical VC Institutions in China”. It has also been elected as “Shenzhen TOP10 VC Institutions” for several consecutive years, and once was theme covered by Nature magazine.


Why choose us?

为什么选择我们

创业板首家生态环境建设上市公司
中国生态修复和环境建设领军企业
国家级高新技术企业
中国环保产业骨干企业

Our histoty

发展历史

< >
  • 公司简介
  • 企业文化
  • 资质荣誉
  • 发展历程
    • Aboutus
      Aboutus
      Shenzhen Efung Capital is one of the earliest venture capital institutions that specialized in biomedicine investment in China. Efung has a high-caliber management team and an experienced investment team, which consist of MDs/PhDs graduated from professional institutions at home and abroad. It focuses on medical and healthcare sectors, especially in VC and PE investment in biopharmaceuticals and high-end medical devices. Throughout these years, Efung has explored profoundly the potentials of healthcare industry, and has invested over 50 prominent companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, Apexigen and Centrexion et al. Efung Capital has demonstrated a solid track record, and has achieved strong revenue and earnings growth. It was recognized as “Zero2IPO Group2020 Best Healthcare Investment Institution TOP30”, “ChinaVenture 2019 Best Exit Cases TOP10”and “The Most Dynamic Pharmaceutical VC Institutions in China”. It has also been elected as “Shenzhen TOP10 VC Institutions” for several consecutive years, and once was theme covered by Nature magazine.
温庚金 总经理

高级景观设计师

城市立体绿化专家

在城市立体绿化领域深耕多年,曾获立体绿化发明专利1项,世界屋顶绿化协会颁发的立体绿化设计与施工资格证书和空中花园建造师专业委员会委员证书,中国风景园林学会科技进步二等奖以及深圳市科技创新委员会颁发的关于《墙面绿化集成新技术研究》成果奖。
Our honor
资质荣誉 +
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务